Search

Your search keyword '"John, Cheville"' showing total 153 results

Search Constraints

Start Over You searched for: Author "John, Cheville" Remove constraint Author: "John, Cheville"
153 results on '"John, Cheville"'

Search Results

1. Role of the tumour microenvironment in bladder cancer pathogenesis and value of the reverse translational approach: a tale of two species

2. Dynamics and survival associations of T cell receptor clusters in patients with pleural mesothelioma treated with immunotherapy

3. Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities

4. Adrenal venous sampling for lateralization of cortisol hypersecretion in patients with bilateral adrenal masses

6. Data from Intratumoral Resolution of Driver Gene Mutation Heterogeneity in Renal Cancer Using Deep Learning

8. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

9. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

10. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

11. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

12. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

13. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

14. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types

15. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

16. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

17. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

18. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

19. 2022-RA-1499-ESGO Differential response of in-vitro mismatch repair-deficient hypermethylated endometrioid endometrial cancer models to DNA-hypomethylating agents

20. The Significance of Squamous Histology on Clinical Outcomes and PD-L1 Expression in Bladder Cancer

21. Abstract 2509: Similar variant histology and immune cell infiltration in canine and human muscle-invasive bladder cancer

22. EXTH-20. IDENTIFICATION OF EX VIVO THERAPEUTIC VULNERABILITIES IN DIFFUSE GLIOMAS USING A FUNCTIONAL GENOMICS APPROACH

25. Survival outcomes of metastasis-directed therapy for solitary sites of metastatic clear cell renal cell carcinoma

26. Evaluation of PD-L1 and B7-H3 expression as a predictor of response to adjuvant chemotherapy in bladder cancer

27. Abstract A036: Surfaceome profiling of rhabdomyosarcoma reveals B7-H3 as a mediator of immune evasion

28. Intratumoral Resolution of Driver Gene Mutation Heterogeneity in Renal Cancer Using Deep Learning

29. Integration of Comprehensive Genomic Analysis and Functional Screening of Affected Molecular Pathways to Inform Cancer Therapy

30. PD46-12 LONG TERM OUTCOMES OF PATIENTS WITH LOW GRADE CYSTIC EPITHELIAL RENAL NEOPLASMS

31. MP32-15 CIGARETTE SMOKING IS ASSOCIATED WITH ADVERSE PATHOLOGIC RESPONSE AND INCREASED DISEASE RECURRENCE AMONG PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER TREATED WITH CISPLATIN-BASED NEOADJUVANT CHEMOTHERAPY AND RADICAL CYSTECTOMY

32. MP25-06 COMPLETE METASTASECTOMY FOR RENAL CELL CARCINOMA IN THE CONTEMPORARY ERA

33. PD52-06 CLINICAL PREDICTORS AND SURVIVAL OUTCOME OF PATIENT RECEIVING SUBOPTIMAL NEOADJUVANT CHEMOTHERAPY AND RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER: A SINGLE-CENTER EXPERIENCE

34. MP09-11 CONTEMPORARY INCIDENCE AND PREDICTORS OF DOWNGRADING FOR GLEASON 8 PROSTATE CANCER: IMPLICATIONS FOR RISK CLASSIFICATION AND TREATMENT

35. MP21-03 CD-70 BLOCKADE AS A NOVEL IMMUNOTHERAPY FOR THE TREATMENT OF CLEAR-CELL RENAL CELL CARCINOMA

36. PD51-03 PERCUTANEOUS ABLATION OFFERS COMPARABLE ONCOLOGIC CONTROL COMPARED WITH PARTIAL NEPHRECTOMY FOR cT1 RENAL MASSES

37. MP34-12 THE ROLE OF SALVAGE LYMPH NODE DISSECTION IN NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS: A SINGLE CENTER EXPERIENCE

38. MP31-07 SIMULTANEOUS VERSUS STAGED PARTIAL NEPHRECTOMIES FOR BILATERAL SYNCHRONOUS SOLID RENAL MASSES

39. PD25-10 ESTIMATION OF THE RISK OF MISSING ADVERSE PATHOLOGICAL PROSTATE CANCER FEATURES AFTER SALVAGE RADICAL PROSTATECTOMY IN PATIENTS ELIGIBLE FOR FOCAL SALVAGE THERAPIES

41. A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples

42. Comprehensive Characterization of Cancer Driver Genes and Mutations

44. PD57-02 CREATION OF A TISSUE EXPRESSION BIOMARKER-AUGMENTED PROGNOSTIC MODEL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

45. PD16-12 PROGNOSTIC EVALUATION OF PERINEPHRIC FAT, RENAL SINUS FAT, AND RENAL VEIN INVASION FOR PATIENTS WITH PATHOLOGIC STAGE T3A RENAL CELL CARCINOMA

46. PD41-07 EXAMINING THE MD ANDERSON RISK CRITERIA FOR PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: ARE LOW RISK PATIENTS HARMED WITH UPFRONT CYSTECTOMY?

47. MP66-12 BIM EXPRESSION IN PERITUMORAL LYMPHOCYTES IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN PATIENTS WITH METASTATIC CLEAR CELL RENAL CELL CARCINOMA

Catalog

Books, media, physical & digital resources